Stemtech Corp (STEK) Form 10-Q — Jun 22, 2026
Stemtech Corp reported a net loss of $1.25 million for the quarter ended March 31, 2026, an improvement from the $1.46 million loss in the prior-year period, driven by expense reductions. Net sales fell 47% year-over-year to $462,957, primarily due to inventory constraints that limited the company's ability to fulfill distributor orders. The company’s financial position remains precarious with a working capital deficit of $10.5 million and cash on hand of $256,149. Management explicitly raised substantial doubt about the company’s ability to continue as a going concern, stating it requires additional capital to fund operations and cannot assure financing will be available.
Key figures
- Eps
- 0
- Revenue
- 462957
- Total Debt
- 4159460
- Revenue Yoy
- -46.7%
- Cash Position
- 256149
- Shares Outstanding
- 1649816690
- Gross margin
- 76.4%
- Gross profit
- 353653
- Working capital deficit
- 10461764
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.